BBR Partners’s AEON Biopharma AEON Stock Holding History

BBR Partners’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-161	Closed	-$6.26K	–	247
2024 Q4	$6.26K	Hold	161	–	–	﹤0.01%	249
2024 Q3	$12.2K	Buy	+161	New	+$14.2K	﹤0.01%	240

Other funds holding AEON

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DCM

Dupont Capital Management Wilmington, Delaware $879M AUM 29.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BBR Partners's AEON Position: Q1 2025 in Review

BBR Partners sold out of AEON Biopharma (AEON) in Q1 2025, closing a stake of 161 shares — an estimated $6.26K sold.

BBR Partners first reported a position in AEON in Q3 2024 and held it in 2 quarters. The position peaked at $12.2K in Q3 2024. 16 funds tracked by Wall St. Rank hold AEON as of Q1 2025.

BBR Partners reported no remaining AEON Biopharma position as of Q1 2025 after selling out during the quarter.
BBR Partners sold 161 AEON Biopharma shares in Q1 2025, an estimated $6.26K.
BBR Partners first reported a position in AEON Biopharma in Q3 2024 and held it in 2 quarters.
BBR Partners's AEON Biopharma position peaked at $12.2K in Q3 2024.
16 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2025.

Based on BBR Partners's 13F filing for Q1 2025, filed 14 May 2025.